Core fucose is critical for CD14-dependent Toll-like receptor 4 signaling

Glycobiology

Volumn 27, Issue 11, 2017, Pages 1006-1015

  Iijima, Junko ^a   Kobayashi, Satoshi ^a   Kitazume, Shinobu ^a   Kizuka, Yasuhiko ^a   Fujinawa, Reiko ^a   Korekane, Hiroaki ^a   Shibata, Takuma ^b   Saitoh, Shin Ichiroh ^b   Akashi Takamura, Sachiko ^c   Miyake, Kensuke ^b   Miyoshi, Eiji ^d   Taniguchi, Naoyuki ^a  

^a RIKEN   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

CD14; core fucose; endocytosis; IFN ; TLR4

Indexed keywords

ALPHA 1,6 FUCOSYLTRANSFERASE; BETA INTERFERON; CD14 ANTIGEN; FUCOSE; FUCOSYLTRANSFERASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G2A; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; LECTIN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 2; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; TOLL LIKE RECEPTOR 4; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; GLYCOPROTEIN 6-ALPHA-L-FUCOSYLTRANSFERASE; LIPOPOLYSACCHARIDE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ENDOCYTOSIS; ENZYME ACTIVATION; FIBROBLAST; FUCOSYLATION; GLYCOSYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PROTEIN PROCESSING;

ANIMALS; FUCOSE; FUCOSYLTRANSFERASES; HEK293 CELLS; HUMANS; INTERFERON-BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDE RECEPTORS; MICE; MICE, INBRED C57BL; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85035070842     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwx075     Document Type: Article

References (59)

1. Akashi S, Saitoh S, Wakabayashi Y, Kikuchi T, Takamura N, Nagai Y, Kusumoto Y, Fukase K, Kusumoto S, Adachi Y et al. 2003. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med. 198: 1035-1042.
2. Akashi-Takamura S, Furuta T, Takahashi K, Tanimura N, Kusumoto Y, Kobayashi T, Saitoh SI, Adachi Y, Doi T, Miyake K. 2006. Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. J Immunol. 176:4244-4251.
3. Beutler B, Du X, Poltorak A. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J Endotoxin Res. 7:277-280.
4. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS et al. 2005. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 102:779-784.
5. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 92:7297-7301.
6. Chen CY, Jan YH, Juan YH, Yang CJ, Huang MS, Yu CJ, Yang PC, Hsiao M, Hsu TL, Wong CH. 2013. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc Natl Acad Sci U S A. 110:630-635.
7. da Silva Correia J, Ulevitch RJ. 2002. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem. 277:1845-1854.
8. Fujii H, Shinzaki S, Iijima H, Wakamatsu K, Iwamoto C, Sobajima T, Kuwahara R, Hiyama S, Hayashi Y, Takamatsu S et al. 2016. Core fucosylation on T cells, required for activation of T-cell receptor signaling and induction of colitis in mice, is increased in patients with inflammatory bowel disease. Gastroenterology. 150:1620-1632.
9. Fukuda T, Hashimoto H, Okayasu N, Kameyama A, Onogi H, Nakagawasai O, Nakazawa T, Kurosawa T, Hao Y, Isaji T et al. 2011. {alpha}1, 6-Fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems. J Biol Chem. 286:18434-18443.
10. Gao C, Maeno T, Ota F, Ueno M, Korekane H, Takamatsu S, Shirato K, Matsumoto A, Kobayashi S, Yoshida K et al. 2012. Sensitivity of heterozygous alpha1, 6-fucosyltransferase knock-out mice to cigarette smoke-induced emphysema: implication of aberrant transforming growth factor-beta signaling and matrix metalloproteinase gene expression. J Biol Chem. 287: 16699-16708.
11. Gu W, Fukuda T, Isaji T, Hang Q, Lee HH, Sakai S, Morise J, Mitoma J, Higashi H, Taniguchi N et al. 2015. Loss of alpha1, 6-fucosyltransferase decreases hippocampal long term potentiation: implications for core fucosylation in the regulation of AMPA receptor heteromerization and cellular signaling. J Biol Chem. 290:17566-17575.
12. Hutchinson WL, Du MQ, Johnson PJ, Williams R. 1991. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology. 13:683-688.
13. Jia W, Lu Z, Fu Y, Wang HP, Wang LH, Chi H, Yuan ZF, Zheng ZB, Song LN, Han HH et al. 2009. A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol Cell Proteomics. 8:913-923.
14. Jin MS, Lee JO. 2008. Structures of the toll-like receptor family and its ligand complexes. Immunity. 29:182-191.
15. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat Immunol. 9:361-368.
16. Kawai T, Akira S. 2006. TLR signaling. Cell Death Differ. 13:816-825.
17. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 11:373-384.
18. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, Akira S. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 167:5887-5894.
19. Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N. 2010. Alpha2, 6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem. 285:6515-6521.
20. Kizuka Y, Kitazume S, Fujinawa R, Saito T, Iwata N, Saido TC, Nakano M, Yamaguchi Y, Hashimoto Y, Staufenbiel M et al. 2015. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease. EMBO Mol Med. 7:175-189.
21. Kondo Y, Ikeda K, Tokuda N, Nishitani C, Ohto U, Akashi-Takamura S, Ito Y, Uchikawa M, Kuroki Y, Taguchi R et al. 2013. TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc Natl Acad Sci U S A. 110:4714-4719.
22. Kurt-Jones EA, Sandor F, Ortiz Y, Bowen GN, Counter SL, Wang TC, Finberg RW. 2004. Use of murine embryonic fibroblasts to define Tolllike receptor activation and specificity. J Endotoxin Res. 10:419-424.
23. Lakshminarayan R, Wunder C, Becken U, Howes MT, Benzing C, Arumugam S, Sales S, Ariotti N, Chambon V, Lamaze C et al. 2014. Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrinindependent carriers. Nat Cell Biol. 16:595-606.
24. Lien E, Aukrust P, Sundan A, Muller F, Froland SS, Espevik T. 1998. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood. 92:2084-2092.
25. Lin H, Wang D, Wu T, Dong C, Shen N, Sun Y, Sun Y, Xie H, Wang N, Shan L. 2011. Blocking core fucosylation of TGF-beta1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol. 300: F1017-F1025.
26. Lloyd-Jones KL, Kelly MM, Kubes P. 2008. Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J Immunol. 181:1446-1453.
27. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704-715.
28. Matsumiya S, Yamaguchi Y, Saito J, Nagano M, Sasakawa H, Otaki S, Satoh M, Shitara K, Kato K. 2007. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol. 368:767-779.
29. Matsumura K, Higashida K, Ishida H, Hata Y, Yamamoto K, Shigeta M, Mizuno-Horikawa Y, Wang X, Miyoshi E, Gu J et al. 2007. Carbohydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: a novel probe for core fucose. J Biol Chem. 282:15700-15708.
30. Meng J, Parroche P, Golenbock DT, McKnight CJ. 2008. The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. J Biol Chem. 283:3376-3384.
31. Muinelo-Romay L, Vazquez-Martin C, Villar-Portela S, Cuevas E, Gil-Martin E, Fernandez-Briera A. 2008. Expression and enzyme activity of alpha(1, 6)fucosyltransferase in human colorectal cancer. Int J Cancer. 123:641-646.
32. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol. 3:667-672.
33. Nakagawa T, Uozumi N, Nakano M, Mizuno-Horikawa Y, Okuyama N, Taguchi T, Gu J, Kondo A, Taniguchi N, Miyoshi E. 2006. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. J Biol Chem. 281:29797-29806.
34. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. 2005. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell. 123:1307-1321.
35. Okazaki A, Shoji-Hosaka E, Nakamura K, Wakitani M, Uchida K, Kakita S, Tsumoto K, Kumagai I, Shitara K. 2004. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J Mol Biol. 336:1239-1249.
36. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H. 2006. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer. 118:2803-2808.
37. Orr SL, Le D, Long JM, Sobieszczuk P, Ma B, Tian H, Fang X, Paulson JC, Marth JD, Varki N. 2013. A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycanbinding proteins. Glycobiology. 23:363-380.
38. Osumi D, Takahashi M, Miyoshi E, Yokoe S, Lee SH, Noda K, Nakamori S, Gu J, Ikeda Y, Kuroki Y et al. 2009. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 100:888-895.
39. Ota F, Kizuka Y, Kitazume S, Adachi T, Taniguchi N. 2016. N-Glycosylation is essential for the secretion of extracellular superoxide dismutase. FEBS Lett. 590:3357-3367.
40. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 458:1191-1195.
41. Pinho SS, Reis CA. 2015. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 15:540-555.
42. Plociennikowska A, Hromada-Judycka A, Borzecka K, Kwiatkowska K. 2015. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 72:557-581.
43. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C et al. 1998. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282: 2085-2088.
44. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M et al. 2003. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 278:3466-3473.
45. Takahashi T, Ikeda Y, Miyoshi E, Yaginuma Y, Ishikawa M, Taniguchi N. 2000. alpha1, 6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer. 88:914-919.
46. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T, Hirai H. 1993. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 53:5419-5423.
47. Tan Z, Yin H, Nie S, Lin Z, Zhu J, Ruffin MT, Anderson MA, Simeone DM, Lubman DM. 2015. Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. J Proteome Res. 14:1968-1978.
48. Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K. 2008. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun. 368:94-99.
49. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442-454.
50. Tong Y, Cui J, Li Q, Zou J, Wang HY, Wang RF. 2012. Enhanced TLRinduced NF-kappaB signaling and type I interferon responses in NLRC5 deficient mice. Cell Res. 22:822-835.
51. Wakabayashi Y, Kobayashi M, Akashi-Takamura S, Tanimura N, Konno K, Takahashi K, Ishii T, Mizutani T, Iba H, Kouro T et al. 2006. A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J Immunol. 177:1772-1779.
52. Wang X, Fukuda T, Li W, Gao CX, Kondo A, Matsumoto A, Miyoshi E, Taniguchi N, Gu J. 2009. Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice. J Biochem. 145: 643-651.
53. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N. 2006. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem. 281:2572-2577.
54. Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M et al. 2005. Dysregulation of TGFbeta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci U S A. 102:15791-15796.
55. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1431-1433.
56. Yin H, Tan Z, Wu J, Zhu J, Shedden KA, Marrero J, Lubman DM. 2015. Mass-selected site-specific core-fucosylation of serum proteins in hepatocellular carcinoma. J Proteome Res. 14:4876-4884.
57. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. 2011. CD14 controls the LPS-induced endocytosis of Tolllike receptor 4. Cell. 147:868-880.
58. Zhang X, Shan P, Jiang G, Cohn L, Lee PJ. 2006. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest. 116:3050-3059.
59. Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J. 2006. Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem. 281:38343-38350.